Antonio Lupia was born in Catanzaro (Italy) on March 7th, 1989. In 2015 he received the degree in Pharmacy at the University "Magna Græcia" of Catanzaro, discussing an experimental thesis titled "Identification of new selective bioactive ligands for phospho-tyrosine-phosphatase 1B", under the supervision of Prof. Anna Artese and the professor Gerhard Wolber, Frëie University of Berlin. In 2019, at the University Magna Græcia of Catanzaro, he reached the PhD degrees in Life Sciences defending a thesis entitled "Molecular modelling of epitopes recognised by neoplastic B-cells in Chronic Lymphocytic Leukemia", also receiving the Paul Ehrlich Euro-PhD award. Dr Antonio Lupia has been deeply involved in in-silico computational analysis of epitopic reactivity of tumour B cell clones in Chronic Lymphocytic Leukaemia (CLL). During the PhD training program, he spent a period at the Institute of Oncology Research of Bellinzona where used in-silico computational methods for the studying of tumour targets for promising ligands, under the supervisors of Dr Francesco Bertoni and Dr Eugenio Gaudio. Furthermore, thanks to Dr Luciano Cascione, he acquired knowledge of new bioinformatics tools. To date, he joined Net4Science academic spin-off based in Catanzaro, where he works as a computational chemist. The scientific interests concern the application of new computational methods for the study of intermolecular drug-receptor interactions and the design of potential anticancer drugs.